Summary: 

Discuss current evidence suggesting that acetazolamide in addition to standardized loop diuretics is more successful in treating volume overload associated with decompensated heart failure

Objectives:

At the conclusion of this activity, the learner should be able to:

Describe the mechanism of action of acetazolamide

Recognize the Acetazolamide in Acute Decompensated Heart Failure with Volume Overload trial

Appraise the use of acetazolamide in conjunction with loop diuretic therapy for treatment of decompensated heart failure

Bio:

Reena Yaman completed her undergraduate training in Chemistry and Psychology at the University of Toronto Mississauga, graduate training in medical science researching biomarkers for autoimmune diseases at the University of Toronto, and medical school training at the Mayo Clinic Alix School of Medicine in Arizona. She is a second-year Internal Medicine resident at Mayo Clinic Arizona.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.